This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (21)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Can Lytic Therapy Be Justified?

Jaan Sidorov, MD

Arch Intern Med. 1989;149(8):1841-1845.

Abstract
• Lytic therapy, most notably streptokinase, holds great promise in the treatment of acute deep venous thrombosis. In 19 published trials, this form of lytic therapy has been shown to be associated with greater venous valvular and venous patency preservation, implying better short-term and long-term outcome. Unfortunately, closer examination of the data reveals several flaws, including overreliance on venogram data and lack of adequate long-term follow-up. Streptokinase, as well as other forms of lytic therapy, has not gained widespread acceptance in the treatment of acute deep venous thrombosis, and, until better data become available, such reluctance seems justified.

(Arch Intern Med. 1989;149:1841-1845)

Author Affiliations
From the Geisinger Medical Center, Danville, Pa.

Footnotes
Accepted for publication May 4,1989.

Reprint requests to Geisinger Medical Center, Danville, PA 17822 (Dr Sidorov).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?